GAMA, L. G. .; CABO, C. J. . Safety profile of Trastuzumab deruxtecan in patients with advanced HER2+ breast cancer: an active pharmacovigilance study. Journal of Hospital Pharmacy and Health Services, [S. l.], v. 16, n. 2, p. e1259, 2025. DOI: 10.30968/jhphs.2025.162.1259. Disponível em: https://jhphs.org/sbrafh/article/view/1259. Acesso em: 30 jun. 2025.